Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 667,800 shares, a decrease of 10.7% from the November 15th total of 747,900 shares. Based on an average trading volume of 184,500 shares, the days-to-cover ratio is presently 3.6 days. Currently, 2.1% of the company's shares are short sold.
Analysts Set New Price Targets
BIOX has been the topic of several research analyst reports. Canaccord Genuity Group decreased their target price on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating on the stock in a research report on Wednesday, November 13th. Lake Street Capital decreased their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating on the stock in a report on Wednesday, September 11th. Oppenheimer lowered their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating for the company in a research note on Monday, October 21st. Finally, Roth Mkm cut their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating on the stock in a research report on Wednesday, September 11th. Four analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $12.13.
Get Our Latest Research Report on Bioceres Crop Solutions
Bioceres Crop Solutions Trading Up 0.8 %
BIOX stock traded up $0.05 during midday trading on Friday, reaching $6.66. 120,315 shares of the company's stock traded hands, compared to its average volume of 100,017. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. Bioceres Crop Solutions has a fifty-two week low of $5.71 and a fifty-two week high of $14.05. The business has a 50-day moving average price of $6.85 and a two-hundred day moving average price of $9.01. The company has a market capitalization of $418.58 million, a P/E ratio of 333.17 and a beta of 0.51.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same quarter in the previous year, the firm posted ($0.07) EPS. Equities research analysts forecast that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.
Institutional Investors Weigh In On Bioceres Crop Solutions
A number of large investors have recently modified their holdings of BIOX. Fourth Sail Capital LP boosted its holdings in Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock worth $24,957,000 after acquiring an additional 1,209,277 shares during the period. Long Focus Capital Management LLC boosted its stake in shares of Bioceres Crop Solutions by 19.9% in the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company's stock valued at $3,145,000 after purchasing an additional 46,647 shares during the period. Oak Family Advisors LLC boosted its stake in shares of Bioceres Crop Solutions by 1.9% in the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company's stock valued at $728,000 after purchasing an additional 1,208 shares during the period. Dimensional Fund Advisors LP grew its holdings in Bioceres Crop Solutions by 9.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock valued at $688,000 after purchasing an additional 5,341 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Bioceres Crop Solutions during the 2nd quarter worth $472,000. Institutional investors and hedge funds own 17.68% of the company's stock.
About Bioceres Crop Solutions
(
Get Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.